Bayer said the number of plaintiffs alleging the company’s newly acquired weed killers cause cancer has risen sharply, adding to concerns about potentially costly litigation stemming from its acquisition of Monsanto.
from WSJ.com: US Business https://ift.tt/2wMNzyP
via IFTTT
No comments:
Post a Comment